FDA’s Hahn Says The Agency Is Meeting Its MDUFA Review Goals – For Now
Executive Summary
US FDA commissioner Stephen Hahn says in a 16 April communique that the agency is still performing “user-fee review activities” despite the ongoing coronavirus pandemic – but he warns that the FDA might not be able to do so “indefinitely.”